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Introduction
Missense mutations in cryopyrin (NLRP3) result in a
hyperactive inflammasome that drives overproduction of
the pro-inflammatory cytokines interleukin-1b (IL-1b) and
IL-18. Mice expressing mutations associated with familial
cold autoinflammatory syndrome (FCAS) or Muckle-
Wells syndrome (MWS) exhibit severe, spontaneous
inflammation, early death, and hyperresponsiveness to sti-
muli in vitro. Abrogating IL-1 signaling either genetically
or pharmacologically results in modest improvement of
life expectancy in murine CAPS, but clearly indicates a
role for players in addition to IL-1b.
Objectives
To examine the role of other caspase-1 dependent media-
tors, namely IL-18, in the context of inflammasome-
mediated disease.
Methods
Mice heterozygous for the A350V MWS mutation or the
L351P NOMID mutation were bred to IL-1R-/- or IL-
18R-/- knockout mice, and weighed and assessed daily.
Bone marrow macrophages and peritoneal cells were eval-
uated in vitro with inflammatory stimuli. Peripheral blood
was drawn for complete blood counts and serum cytokine
analyses. Pathology was examined in both young and old
mice. Bone marrow transplant experiments were used to
elucidate the role of cellular signaling compartments.
Results
Similar to IL-1b, hematopoietic cells derived from our
mutant mice and monocytes from FCAS patients hyper-
secrete IL-18, in response to low amounts of inflammatory
stimuli or cold temperature. Breeding Nlrp3 mutations
onto an IL-18R null background resulted in partial
phenotypic rescue that abolished skin and visceral disease
in young mice, and normalized serum cytokines to a
greater extent than breeding to IL-1R null mice. However,
significant systemic inflammation developed in aging
Nlrp3 mutant IL-18R null mice, implicating a role for pyr-
optosis, a caspase-1 mediated form of cell death. Bone
marrow transplant studies demonstrate that hematopoietic
cells are driving disease in murine CAPS but signaling
requirements differ between IL-1 and IL-18.
Conclusion
These studies demonstrate a previously underappreciated
role for IL-18 signaling in murine CAPS pathogenesis.
We also confirm our previous findings that CAPS is
inflammasome-dependent by demonstrating that intact
caspase-1 is required for disease, yet other downstream
mechanisms besides IL-18 and IL-1b mediated inflamma-
tion are involved in this autoinflammatory syndrome con-
stellation. Our results may have important implications for
patients with CAPS and residual disease and emphasize
the need to explore other NLRP3 mediated pathways and
the potential for inflammasome targeted therapy.
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